Graft versus host disease: New insights into A2A receptor agonist therapy

Computational and Structural Biotechnology Journal

Volumn 13, Issue , 2015, Pages 101-105

  Jones, Karlie R ^a   Kang, Elizabeth M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Adenosine; Adenosine A2A receptor agonist; FoxP3; Graft versus host disease; Inflammation; Regulatory T cell

Indexed keywords

ADENOSINE A2A RECEPTOR AGONIST; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3;

ALLOTRANSPLANTATION; ANTIGEN PRESENTING CELL; BIOTECHNOLOGY; CHRONIC GRANULOMATOUS DISEASE; DIABETIC NEPHROPATHY; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; NATIONAL HEALTH ORGANIZATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SICKLE CELL ANEMIA; T LYMPHOCYTE ACTIVATION;

EID: 84948779686     PISSN: None     EISSN: 20010370     Source Type: Journal    
DOI: 10.1016/j.csbj.2014.12.003     Document Type: Review

References (50)

1. C. Messina, M. Faraci, V. de Fazio, G. Dini, M.P. Calo, and E. Calore Prevention and treatment of acute GvHD Bone Marrow Transplant 41 Suppl. 2 2008 S65 S70
2. K.L. Han, S.V. Thomas, S.M. Koontz, C.M. Changpriroa, S.K. Ha, H.L. Malech, and et al. Adenosine A(2)A receptor agonist-mediated increase in donor-derived regulatory T cells suppresses development of graft-versus-host disease J Immunol 190 2013 458 468
3. C.M. Lappas, P.C. Liu, J. Linden, E.M. Kang, and H.L. Malech Adenosine A2A receptor activation limits graft-versus-host disease after allogenic hematopoietic stem cell transplantation J Leukoc Biol 87 2010 345 354
4. D.A. Jacobsohn, and G.B. Vogelsang Acute graft versus host disease Orphanet J Rare Dis 2 2007 35
5. J.R. Westin, R.M. Saliba, M. De Lima, A. Alousi, C. Hosing, M.H. Qazilbash, and et al. Steroid-refractory acute GVHD: predictors and outcomes Adv Hematol 2011 2011 601953
6. J. Peccatori, A. Forcina, D. Clerici, R. Crocchiolo, L. Vago, M.T.L. Stanghellini, and et al. Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors Leukemia 10 2014 1038
7. A. Ohta, R. Kini, A. Ohta, M. Subramanian, M. Madasu, and M. Sitkovsky The development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway Front Immunol 3 2012 190
8. A. Melani, F. Corti, L. Cellai, M. Giuliana Vannucchi, and F. Pedata Low doses of the selective adenosine A2A receptor agonist CGS21680 are protective in a rat model of transient cerebral ischemia Brain Res 1551 2014 59 72
9. M. Naganuma, E.B. Wiznerowicz, C.M. Lappas, J. Linden, M.T. Worthington, and P.B. Ernst Cutting edge: critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis J Immunol 177 2006 2765 2769
10. J.J. Field, G. Lin, M.M. Okam, E. Majerus, J. Keefer, O. Onyekwere, and et al. Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson Blood 121 2013 3329 3334
11. J. Arasa, P. Martos, M.C. Terencio, F. Valcuende-Cavero, and M.C. Montesinos Topical application of the adenosine A2A receptor agonist CGS-21680 prevents phorbol-induced epidermal hyperplasia and inflammation in mice Exp Dermatol 23 2014 555 560
12. F.L. Dignan, A. Clark, P. Amrolia, J. Cornish, G. Jackson, P. Mahendra, and et al. Diagnosis and management of acute graft-versus-host disease Br J Haematol 158 2012 30 45
13. J.L. Ferrara, R. Levy, and N.J. Chao Pathophysiologic mechanisms of acute graft-vs.-host disease Biol Blood Marrow Transplant 5 1999 347 356
14. S. Quellmann, G. Schwarzer, K. Hubel, A. Greb, A. Engert, and J. Bohlius Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantation Cochrane Database Syst Rev 2008 CD004885
15. S. Sakaguchi, T. Yamaguchi, T. Nomura, and M. Ono Regulatory T cells and immune tolerance Cell 133 2008 775 787
16. S. Sakaguchi, K. Wing, Y. Onishi, P. Prieto-Martin, and T. Yamaguchi Regulatory T cells: how do they suppress immune responses? Int Immunol 21 2009 1105 1111
17. S. Sakaguchi, T. Takahashi, and Y. Nishizuka Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis J Exp Med 156 1982 1577 1586
18. S. Sakaguchi, K. Fukuma, K. Kuribayashi, and T. Masuda Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease J Exp Med 161 1985 72 87
19. J. Kim, K. Lahl, S. Hori, C. Loddenkemper, A. Chaudhry, P. deRoos, and et al. Cutting edge: depletion of Foxp3 + cells leads to induction of autoimmunity by specific ablation of regulatory T cells in genetically targeted mice J Immunol 183 2009 7631 7634
20. T.R. Malek, A. Yu, V. Vincek, P. Scibelli, and L. Kong CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2 Immunity 17 2002 167 178
21. T.A. Chatila, F. Blaeser, N. Ho, H.M. Lederman, C. Voulgaropoulos, C. Helms, and et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome J Clin Invest 106 2000 R75 R81
22. R.S. Wildin, F. Ramsdell, J. Peake, F. Faravelli, J.L. Casanova, N. Buist, and et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy Nat Genet 27 2001 18 20
23. C.L. Bennett, J. Christie, F. Ramsdell, M.E. Brunkow, P.J. Ferguson, L. Whitesell, and et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 Nat Genet 27 2001 20 21
24. B.B. Fredholm, E. Irenius, B. Kull, and G. Schulte Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells Biochem Pharmacol 61 2001 443 448
25. A.P.I.J. Fredholm BB, K.A. Jacobson, K.N. Klotz, and J. Linden International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors Pharmacol Rev 53 2001 527 552
26. A. Ohta, and M. Sitkovsky Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage Nature 414 2001 916 920
27. J.J. Kobie, P.R. Shah, L. Yang, J.A. Rebhahn, D.J. Fowell, and T.R. Mosmann T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine J Immunol 177 2006 6780 6786
28. S. Deaglio, K.M. Dwyer, W. Gao, D. Friedman, A. Usheva, A. Erat, and et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression J Exp Med 204 2007 1257 1265
29. P.E. Zarek, C.T. Huang, E.R. Lutz, J. Kowalski, M.R. Horton, J. Linden, and et al. A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells Blood 111 2008 251 259
30. G.H. Moser, J. Schrader, and A. Deussen Turnover of adenosine in plasma of human and dog blood Am J Physiol 256 1989 C799 C806
31. A. Ohta, and M. Sitkovsky Extracellular adenosine-mediated modulation of regulatory T cells Front Immunol 5 2014 304
32. G.W. Sullivan, G. Fang, J. Linden, and W.M. Scheld A2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis J Infect Dis 189 2004 1897 1904
33. C.M. Lappas, Y.J. Day, M.A. Marshall, V.H. Engelhard, and J. Linden Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation J Exp Med 203 2006 2639 2648
34. M.C. Montesinos, A. Desai, and B.N. Cronstein Suppression of inflammation by low-dose methotrexate is mediated by adenosine A2A receptor but not A3 receptor activation in thioglycollate-induced peritonitis Arthritis Res Ther 8 2006 R53
35. J.F. Chen, H.K. Eltzschig, and B.B. Fredholm Adenosine receptors as drug targets - what are the challenges? Nat Rev Drug Discov 12 2013 265 286
36. A.S. Awad, L. Huang, H. Ye, E.T. Duong, W.K. Bolton, J. Linden, and et al. Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy Am J Physiol Renal Physiol 290 2006 F828 F837
37. D. Wolf, A.M. Wolf, D. Fong, H. Rumpold, A. Strasak, J. Clausen, and et al. Regulatory T-cells in the graft and the risk of acute graft-versus-host disease after allogeneic stem cell transplantation Transplantation 83 2007 1107 1113
38. D. Hashimoto, S. Asakura, K. Matsuoka, Y. Sakoda, M. Koyama, K. Aoyama, and et al. FTY720 enhances the activation-induced apoptosis of donor T cells and modulates graft-versus-host disease Eur J Immunol 37 2007 271 281
39. A. Trenado, M. Sudres, Q. Tang, S. Maury, F. Charlotte, S. Gregoire, and et al. Ex vivo-expanded CD4 + CD25 + immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T cells J Immunol 176 2006 1266 1273
40. M.J. O'Shaughnessy, Z.M. Chen, I. Gramaglia, P.A. Taylor, A. Panoskaltsis-Mortari, C. Vogtenhuber, and et al. Elevation of intracellular cyclic AMP in alloreactive CD4(+) T Cells induces alloantigen-specific tolerance that can prevent GVHD lethality in vivo Biol Blood Marrow Transplant 13 2007 530 542
41. F.T. Hakim, S.O. Sharrow, S. Payne, and G.M. Shearer Repopulation of host lymphohematopoietic systems by donor cells during graft-versus-host reaction in unirradiated adult F1 mice injected with parental lymphocytes J Immunol 146 1991 2108 2115
42. C.S. Via, and F.D. Finkelman Critical role of interleukin-2 in the development of acute graft-versus-host disease Int Immunol 5 1993 565 572
43. C.S. Via, S.O. Sharrow, and G.M. Shearer Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease J Immunol 139 1987 1840 1849
44. B. Mayr, and M. Montminy Transcriptional regulation by the phosphorylation-dependent factor CREB Nat Rev Mol Cell Biol 2 2001 599 609
45. J.K. Polansky, L. Schreiber, C. Thelemann, L. Ludwig, M. Kruger, R. Baumgrass, and et al. Methylation matters: binding of Ets-1 to the demethylated Foxp3 gene contributes to the stabilization of Foxp3 expression in regulatory T cells J Mol Med (Berl) 88 2010 1029 1040
46. J.K. Polansky, K. Kretschmer, J. Freyer, S. Floess, A. Garbe, U. Baron, and et al. DNA methylation controls Foxp3 gene expression Eur J Immunol 38 2008 1654 1663
47. H.P. Kim, and W.J. Leonard CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation J Exp Med 204 2007 1543 1551
48. Q. Ruan, V. Kameswaran, Y. Tone, L. Li, H.C. Liou, M.I. Greene, and et al. Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome Immunity 31 2009 932 940
49. K. Bshesh, B. Zhao, D. Spight, I. Biaggioni, I. Feokistov, A. Denenberg, and et al. The A2A receptor mediates an endogenous regulatory pathway of cytokine expression in THP-1 cells J Leukoc Biol 72 2002 1027 1036
50. M.J. Chiang, M.A. Holbert, J.H. Kalin, Y.H. Ahn, J. Giddens, M.N. Amin, and et al. An Fc domain protein-small molecule conjugate as an enhanced immunomodulator J Am Chem Soc 136 2014 3370 3373